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Abstract
Background: From 2005 to 2010, we conducted 2 randomized studies on a journal (Medicina Clínica), where we
took manuscripts received for publication and randomly assigned them to either the standard editorial process or
to additional processes. Both studies were based on the use of methodological reviewers and reporting guidelines
(RG). Those interventions slightly improved the items reported on the Manuscript Quality Assessment Instrument
(MQAI), which assesses the quality of the research report. However, masked evaluators were able to guess the
allocated group in 62% (56/90) of the papers, thus presenting a risk of detection bias. In this post-hoc study, we
analyse whether those interventions that were originally designed for improving the completeness of manuscript
reporting may have had an effect on the number of citations, which is the measured outcome that we used.
Methods: Masked to the intervention group, one of us used the Web of Science (WoS) to quantify the number of
citations that the participating manuscripts received up December 2016. We calculated the mean citation ratio
between intervention arms and then quantified the uncertainty of it by means of the Jackknife method, which
avoids assumptions about the distribution shape.
Results: Our study included 191 articles (99 and 92, respectively) from the two previous studies, which all together
received 1336 citations. In both studies, the groups subjected to additional processes showed higher averages,
standard deviations and annual rates. The intervention effect was similar in both studies, with a combined estimate
of a 43% (95% CI: 3 to 98%) increase in the number of citations.
Conclusions: We interpret that those effects are driven mainly by introducing into the editorial process a senior
methodologist to find missing RG items. Those results are promising, but not definitive due to the exploratory
nature of the study and some important caveats such as: the limitations of using the number of citations as a
measure of scientific impact; and the fact that our study is based on a single journal. We invite journals to perform
their own studies to ascertain whether or not scientific repercussion is increased by adhering to reporting
guidelines and further involving statisticians in the editorial process.
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Background
The full progress of science relies on peer review, yet
many have called into question the benefits of peer review
[1–7]. In essence, critics assert that “studies have shown
that peer reviewers were not able to appropriately detect
errors, improve the completeness of reporting, or decrease
the distortion of the study results” [8]. Nevertheless, the
purposes for which Reporting Guidelines (RG) have been
developed over the past two decades are to help authors,
editors and peer reviewers check and improve the trans-
parency of research studies while ensuring that papers
are both accurate and complete [9–14]. According to
the systematic review published by Bruce et al. (2016) [8],
which we expand on in Section 7 of the Additional file 1,
at least 23 randomized trials have studied some aspects of
the peer review process, with the majority of them focus-
ing on the quality of peer review as a surrogate outcome
while only 3 [15–17] analysed the completeness of report-
ing as an outcome. Of these 3 trials that we previously
conducted, only 2 [15, 16] found positive results regarding
completeness of reporting — although only one of these
reached statistical significance. Those studies were based
on a partly subjective outcome, the Manuscript Quality
Assessment Instrument (MQAI) [18], and there is evi-
dence that evaluators could have successfully guessed
which were in the intervention group [8]. Consequently,
raters could have favoured the group receiving an
additional intervention, thus raising the risk of detection
bias. Therefore, we follow up on those studies here by
taking advantage of the Web of Science [19] (WoS) to
reassess those 2 trials by using the number of citations
later received by those papers. We consider such a mea-
sured outcome to be impartial and fair, as it is naturally
free from the risk of evaluation bias. The relationship
between the completeness of a report and the number of
citations has been previously studied, with promising
though not statistically significant results having been
found [20, 21]. We also previously explored this relation-
ship with a shorter follow-up (SM, Sections 5 and 6).
Methods
We conducted two previous trials [15, 16], in which we
found partially positive results from adding statistical
reviewers and RGs to the peer review process. The first
one was conducted in 2007 and called the “Improve
Quality” (IQ) study [15], in which we randomly allocated
129 suitable manuscripts into 4 intervention groups
(Fig. 1a). Unfortunately, after peer review, 16 manu-
scripts were rejected and 14 were lost to follow-up.
Those losses introduced unpredictable (attrition) bias
[22, 23] and may have affected the estimates.
The second trial was the 2011 “Enhance Transparency”
(ET) study [16], in which we randomized 92 manuscripts
either to both a statistical review and RGs or to neither
(Fig. 1b). In both the IQ and ET studies, the main out-
come was an assessed rather than measured endpoint.
As masked evaluators were able to guess the interven-
tion arm more often than could be ascribed to chance,
partially unblinded evaluators could have introduced
detection bias in both studies [8].
Due to these limitations, and in order to assess the
long-term impact of those interventions, we adopted a
new main outcome: the number of citations that each
paper received on the WoS from publication up to
December 312,016, with our hypothesis being that
greater transparency and more comprehensible report-
ing may facilitate an increase in citations.
The IQ study divided the papers into 4 groups as a
result of combining the two interventions into a 2 × 2
factorial design: a suggestion to the reviewers to employ
an abridged checklist for the evaluation of basic biomed-
ical research papers (C) [24]; and adding a statistician
(S) from the reviewer panel list. Consequently, the 4
groups were defined as: papers which received a stand-
ard review process (reference), papers which received a
review process using a local checklist (C), papers which
received a standard review process and a revision from a
statistician (S) and papers which received a standard
review process and a revision from a statistician using a
local checklist (SC). The reference intervention followed
the usual journal process based on 1–3 reviewers. In
order to combine those results with those of the ET
study, only the 24 papers allocated to the group with
both interventions (C and S) and the 27 allocated to the
reference group (neither C nor S) were now included in
the main analysis.
The ET study modified this design in 3 ways: first, by
relying on just one senior methodological expert rather
than choosing a statistical reviewer from an expert list;
second, by combining both interventions, with the se-
nior methodological reviewer proposing specific changes
based on relevant international reporting guidelines;
and, third, it avoided attrition by delaying the interven-
tion until the decision had been made on whether or not
to publish.
Masked to the intervention group, one of us (MV)
collected from WoS the number of citations that the ET
and IQ articles received. A search was made using the
website’s search tab and including 3 references: (1) the
publication name, “Medicina Clinica (Barcelona)”; (2)
the publication year (either 2004 to 2005 or 2009 to
2010); and, (3) either the article’s title or by searching
for the topic in order to consider posterior changes to
the title (between the submitted and finally published
version). Baseline MQAI and study group were obtained
from the data of the ET and IQ studies.
We aim to estimate the ratio of the average
citation-per-year between intervention arms (which we
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refer to in this paper as “mean citation ratio”). As the
data did not fit to the distributional assumptions of the
previously masked specified Poisson model, our main
analysis relies on the more robust Jackknife method,
which provides wider and more conservative intervals.
As sensitivity analyses, we also report alternative ana-
lyses such as the previously mentioned Poisson model
(Sections 2 to 4 of SM).
Additional collected variables are described in Section
1 of SM. Section 6 of SM and the master’s thesis of the
first author [25] show the results of other exploratory
data analyses that were previously performed with
shorter follow-up.
Analyses were performed using R software version
3.2.1.
Availability of data and materials
The dataset supporting the conclusions of this article
is available at https://www-eio.upc.edu/redir/Number
Citations, where researchers can: (1) reproduce the
results of our analysis; (2) check our data at the Web
of Science [19] as of December 2016; and (3) update
the number of citations in order to replicate our re-
sults with a longer follow-up. The critical scientist
can try to reproduce both our outcome measurements
and analyses.
Results
Of the 129 randomized papers, 99 IQ articles were pub-
lished between 4 February 2005 and 12 May 2006, with
a mean (standard deviation (SD)) follow-up period of
11.35 (0.31) years. Those publications received a total of
927 citations (mean 9.36, SD 14.87). ET included 92
randomized papers that were published between 24 June
2009 and 3 April 2010, with a mean (SD) follow-up
period of 7.29 (0.31) years. They received a total of 409
citations (mean 4.44, SD 4.08). In both studies, the
group with both interventions had larger means, stand-
ard deviations and annual rates. All intervention groups
also had a slightly increased number of articles with 0
citations (Table 1 and Fig. 2).
Figure 3 shows positive intervention effects that are
similar in both studies. Combining both estimates, the
intervention increased the citation rate by 43% (95%CI: 3
to 98%). This effect is due mainly to the ET study, which
has higher weight (85.9) in the meta-analysis due to a
more precise estimate. The weight of the studies within
the meta-analysis has been calculated from the inverse
of the variances of mean ratio estimates, thereby obtain-
ing 31.58 and 5.17 for ET and IQ, respectively.
All analyses show some intervention effect (Fig. 3),
which is slightly larger in the ET study while there is
greater uncertainty from random error in the IQ study.
In order to check the robustness of the results, we ran
sensitivity analyses: a pre-specified Poisson model (which
provided shorter and consequently more-precise confi-
dence intervals); and alternative statistical models that
were suitable for count data (Sections 2 to 4 in SM). All
together, these provided consistent results.
Discussion
If we consider both studies together, we find that includ-
ing a methodological reviewer (for example, a senior
statistician) who is dedicated to looking for missing RG
items increases the number of citations by 43% (95%CI: 3
to 98%), a result that — if this finding is sustained —
might justify the cost and time expenditure by the jour-
nal [26, 27]. The number of papers with zero-citations
was also higher in the intervention groups of both stud-
ies, which raises the possibility that greater transparency
deters citations for some kinds of papers. This unex-
pected result warrants confirmation in future studies.
To the best of our knowledge, this is the first study
showing that the completeness of reporting is potentially
associated with higher citation counts as a result of a
specific intervention, namely: adding to the peer review
process a methodological expert who ensures that the
reporting guidelines are adhered to. Although the num-
ber of citations is considered by some authors to be an
Fig. 1 Scheme of the allocation of interventions of IQ and ET studies. Groups not included in the main analysis are in a shaded style. R =
reference; C=Checklist; S=Statistician; SC = both Checklist and Statistician
Vilaró et al. BMC Medical Research Methodology          (2019) 19:112 Page 3 of 7
indicator of a paper’s influence [28–32], some have
argued that “citation counts are an indicator more of
impact than of quality or importance” [28]; thus, we
should not conflate the number of citations with re-
search quality [21, 33]. Due to the high uncertainty
behind the IQ study (including the risk of bias due to
attrition) and the weight of the ET study when esti-
mating the combined effects, our interpretation
mainly follows the ET results in that the formal use
of RGs at the end of the editorial phase, after peer
review, leads to an increase in the papers’ potential
scientific value. This interpretation assumes that all
added citations are “positive” in the sense that they
contribute to the body of knowledge.
In interpreting this effect size, we should keep in mind
the uncertainty reflected by the confidence intervals.
Our next important limitation pertains to the fact that
our results rely on just one journal that is not
Table 1 Number of citations by study and intervention group
Number of citations Annual rate Articles with 0
citationsN1 N2 Mean (SD) Median (Max) Mean (SD)
IQ study Standard review process (reference) 37 27 8.4 (12.2) 4 (45) 0.7 (1.1) 1 (3.7%)
Statistician 31 26 8.4 (13.7) 4.5 (67) 0.7 (1.2) 4 (15.4%)
Checklist 32 22 10.3 (18.8) 4.5 (89) 0.9 (1.6) 3 (13.6%)
Statistician + Checklist 29 24 10.7 (15.5) 6.5 (60) 0.9 (1.3) 3 (12.5%)
ET study Standard review process (reference) 41 41 3.6 (2.5) 3 (10) 0.5 (0.3) 2 (4.9%)
Statistician + Checklist 51 51 5.1 (4.9) 3 (19) 0.7 (0.7) 7 (13.7%)
N1 = number of randomized manuscripts; N2 = number of analysed manuscripts
Fig. 2 Number of citations by study and intervention group. Groups not included in the main analysis are in a shaded style
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top-quality and they therefore cannot be transported to
top-tier journals where those interventions have
probably already been implemented. According to the
Scimago Journal Country Rank website, journals with
Impact Factor ≥ 10 account for just 1% (15,259 out of
1,528,749 articles published in 2016) of biomedical
scientific production; thus, our focus is not on the
top-quality journals but on second-tier journals who
could benefit from the intervention.
It is essential that our results be interpreted accord-
ing to the exploratory nature of this extended
follow-up study. First, we did not have enough ad-
vance information to know the fit between our data
and the statistical models. Second, and more import-
antly, we had neither previous studies to sustain the
hypothesis nor a sample size rationale to guarantee
any desired power for testing this hypothesis. There-
fore, in keeping with the American Statistical Associ-
ation (ASA) statement on p-value [34], we should not
interpret the results of any hypothesis test. Accord-
ingly, we should also not be concerned about whether
or not the 95% confidence intervals (CI) include the
neutral value of 1, because there is no such previous
hypothesis. However, as we stated prior to data
collection that our objective is “to estimate the effects
of those interventions on the number of citations”,
selective outcome reporting is of no concern.
Conclusions
Our findings indicate that the citation counts increased
by 43% (95% CI from: 3 to 98%) after including in the
editorial process a methodologist who ensures the
proper reporting of checklist items. As our original stud-
ies were originally designed to test those hypotheses for
a different outcome, this present study was not powered
to test this post-hoc analysis; therefore, our results
should not be interpreted as definitive and they need to
be confirmed in properly powered designs. We invite
journals to perform their own studies to ascertain
whether or not scientific impact is increased, first, by
adhering to reporting guidelines, and second, by further
involving statisticians or methodological experts in the
editorial process.
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